UArizona researchers have created an AI powered data-driven tool to forecast a personalized due date window for expectant mothers utilizing data from commonly worn personal devices like smart rings at various periods in gestation.

Stratofly Research seeks to deploy autonomous constellations of our patent-pending altitude-controlled high-altitude balloons (HABs) to collect higher fidelity in-situ atmospheric weather data in data-sparse areas such as over oceans, to improve weather forecasting.

Two of the HABs we manufacture do not require a lighter-than-air, reducing cost and complexity. Altitude-controlled HABs can autonomously adjust altitude to “ride” opposing winds at different altitudes for station-keeping over regions of interest and performing trajectory maneuvers.

With a 10x cost savings compared with current larger altitude-controlled HABs, these small low-cost HABs allow customers to deploy constellations of smaller payloads in the stratosphere, rather than one primary payload.

We offer a novel topical treatment for ocular degeneration that restores neuronal function and vision with a simple eye drop.

Our data-driven platform integrates high-throughput analytics and AI for next-generation drug discovery. We leverage novel insights into the foundational biologic pathways of neurodegenerative diseases to discover, evaluate, and develop disease-modifying therapeutics for Alzheimer’s disease, frontotemporal dementia (FTD) , amyotrophic lateral sclerosis (ALS), and other degenerative diseases of the nervous system.

Many cancer drugs suffer from severe adverse effects due to acute high exposure and inadequate distribution to tumors. This technology provides a vehicle for the preferred delivery of existing and approved drugs to tumor environments and local release of the active agent, thereby focusing exposure to tissues in need and reducing unwanted side effects.

University of Arizona researchers have developed an affordable precision brace technology for carpal tunnel relief, delivering targeted compression and customized comfort to transform hand health.

Innovations in healthcare are reshaping how we diagnose gynecologic conditions like endometrial cancer, endometriosis and adenomyosis. Our groundbreaking approach focuses on non-invasive sampling coupled with advanced biomarker analysis for early detection, especially among underserved populations. By leveraging integrated technologies, we aim to revolutionize women’s health, offering timely diagnoses, improving outcomes, and ultimately saving lives. Join us in our mission to make early detection of gynecologic conditions accessible to all women, regardless of their background or resources.

Precision anti-infective technology focused on a microbiome sparing strategy. We target Clostridioides difficile infection (CDI), an antibiotic-associated infectious diarrheal disease, through oral delivery of a targeted Antisense Oligonucleotide.